CMS Information on Generic Drugs in the Part D Coverage Gap

The Centers for Medicare & Medicaid Services (CMS) has released a memo to Part D Plan Sponsors on "Additional Guidance on 2011 Coverage for Generic Drugs in the Coverage Gap." The memo responds to questions CMS has received about 2011 bid submissions and the new provision regarding coverage for generic drugs in the coverage gap included in the Affordable Care Act.

Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/205674
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.